Diagnostic Yield of CSF Testing in Infants for Disorders of Biogenic Amine Neurotransmitter Metabolism.
Riley KesslerFrance W FungAmisha PatelNishtha GuptaTrevor McHughAlexander K GonzalezLance RodanChellamani HariniSudha Kilaru KesslerPublished in: Neurology (2024)
Our findings support the case for deimplementation of CSFNT testing as a standard diagnostic test of etiology in infants aged 1 year or younger presenting with neurologic disorders.
Keyphrases